Spotnitz William D, Burks Sandra
The Surgical Therapeutic Advancement Center, Department of Surgery, University of Virginia Health System, Charlottesville, Virginia 22908-1370, USA.
Transfusion. 2008 Jul;48(7):1502-16. doi: 10.1111/j.1537-2995.2008.01703.x. Epub 2008 Apr 14.
The surgical toolbox is expanding, and newer products are being developed to improve results. Reducing blood loss so that bloodless surgery can be performed may help minimize morbidity and length of stay. As patients, hospital administrators, and government regulators desire less invasive procedures, the surgical technical challenge is increasing. More operations are being performed through minimally invasive incisions with laparoscopic, endoscopic, and robotic approaches. In this setting, tools that can reduce bleeding by causing blood to clot, sealing vessels, or gluing tissues are gaining an increasing importance. Thus, hemostats, sealants, and adhesives are becoming a more important element of surgical practice. This review is designed to facilitate the reader's basic knowledge of these tools so that informed choices are made for controlling bleeding in specific clinical situations. Such information is useful for all members of the operative team. The team includes surgeons, anesthesiologists, residents, and nurses as well as hematologists and other medical specialists who may be involved in the perioperative care of surgical patients. An understanding of these therapeutic options may also be helpful to the transfusion service. In some cases, these materials may be stored in the blood bank, and their appropriate use may reduce demand for other transfusion components. The product classification used in this review includes hemostats as represented by product categories that include mechanical agents, active agents, flowables, and fibrin sealants; sealants as represented by fibrin sealants and polyethylene glycol hydrogels; and adhesives as represented by cyanoacrylates and albumin cross-linked with glutaraldehyde. Only those agents approved by the Food and Drug Administration (FDA) and presently available (February 2008) for sale in the United States are discussed in this review.
外科手术工具正在不断扩充,新型产品也在持续研发以改善手术效果。减少失血从而实现无血手术,或许有助于将发病率和住院时长降至最低。鉴于患者、医院管理人员以及政府监管机构都期望采用侵入性更小的手术,外科技术面临的挑战与日俱增。越来越多的手术通过腹腔镜、内镜及机器人辅助等微创切口来实施。在此背景下,能够通过促使血液凝固、封闭血管或黏合组织来减少出血的工具愈发重要。因此,止血剂、密封剂和黏合剂正成为外科手术实践中更为关键的要素。本综述旨在增进读者对这些工具的基础知识,以便在特定临床情形下能做出明智的止血选择。此类信息对手术团队的所有成员都很有用。该团队包括外科医生、麻醉师、住院医师、护士,以及可能参与外科手术患者围手术期护理的血液科医生和其他医学专家。了解这些治疗选择对外科输血服务或许也有帮助。在某些情况下,这些材料可能存放在血库中,其合理使用可能会减少对其他输血成分的需求。本综述中使用的产品分类包括:以机械制剂、活性剂、可流动剂和纤维蛋白密封剂等产品类别为代表的止血剂;以纤维蛋白密封剂和聚乙二醇水凝胶为代表的密封剂;以及以氰基丙烯酸酯和与戊二醛交联的白蛋白为代表的黏合剂。本综述仅讨论那些已获美国食品药品监督管理局(FDA)批准且于2008年2月在美国市面上有售的制剂。